Poly- and perfluoroalkyl substances (PFAS) are present in most supply chains and consumer products. As the regulatory landscape surrounding these chemicals evolves, it is crucial for businesses to start taking action to future-proof their business. Benefits and concerns PFAS are a class of over 10,000 chemicals known for their beneficial...

The European Commission's report this September on the future of European competitiveness provides critical insights into the economic, regulatory, and technological challenges facing various industries, including the medical device and in vitro diagnostic (IVD) sectors. The report, undertaken by Mario Draghi for the Commission, highlights how medtech companies must navigate...

The European Commission's comprehensive report on the future of European competitiveness has identified critical challenges facing the pharmaceuticals industry as well as among a range of other sectors across Europe. The report, which has been presented by Mario Draghi, the former president of the European Central Bank President and ex-prime...

The European Securities and Markets Authority (ESMA) has introduced new guidelines for investment funds that use ESG (environmental, social and governance) or sustainability-related terms in their names. These guidelines are a direct response to the growing concern about greenwashing in the financial sector, where funds may misleadingly market themselves as...